Please login to the form below

Not currently logged in
Email:
Password:

Docetaxel

This page shows the latest Docetaxel news and features for those working in and with pharma, biotech and healthcare.

Daily Brief:  NICE says no to Zytiga, Genentech and UK biotech sign microbiome deal

Daily Brief:  NICE says no to Zytiga, Genentech and UK biotech sign microbiome deal

Around half of patients unable to tolerate conventional chemotherapy (docetaxel) will be left with no life-prolonging treatment option at this early, but crucial stage of treatment, as Zytiga is the

Latest news

More from news
Approximately 1 fully matching, plus 121 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

GDPR and events. What does the pharma industry need to know?
...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...

Infographics